By integrating bulk RNA-seq with scRNA-seq analyses, we pinpointed the pivotal role of SPP1+ macrophages in modulating TIME in liver cancer and demonstrated the inhibition effects of SPP1 in HCC-TAMs. The gene discussed is SPP1; the disease is liver cancer.